ITH is aware of the current issue facing PN supplies across the UK. Whilst these supply problems are unconnected with ITH we remain committed to doing all we can to support as many affected patients as possible. We are in close dialogue with the MHRA and NHS to alleviate the pressure.
ITH response to CPS decision to charge with offences under Section 3 and 33 Health and Safety at Work Act and Section 64 and 67 of the Medicines Act. “As founders of ITH we have every sympathy for all the families affected, regardless of the cause. However, we are disappointed by the decision to charge…Details
ITH Pharma made a successful return to the Clinical Pharmacy Congress 2017 at London Excel on the 12th and 13th May with our largest ever stand. The exhibition provided a chance for us to connect with a large number of our existing customers to discuss present and future plans for the business. Chief amongst the…Details
Over the last year ITH Pharma has witnessed continued growth through all sectors of business and a consistent programme of recruitment. This has enabled us to recruit vital members of staff who we believe will be pivotal in moving our business forward over the coming months and years. In the Quality department Richard Bateman has…Details
We will be returning to The Clinical Pharmacy Congress (CPC) at the ExCeL London, stand C30 on the 12th and 13th May. This will be the largest gathering of the clinical pharmacy profession held in the UK. This year we have invested more in increased floor space, to ensure we can engage with a wider…Details